News
Recursion (NASDAQ: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives today announced the acquisition of Rallybio’s (NASDAQ: RLYB) full interest in their joint ...
While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.
As a physician-centric, AI-powered organization, Astrana sees the acquisition as a way to scale its proactive, high-quality care model using proprietary tech and data infrastructure. The company ...
Recursion Pharmaceuticals axes three drug programs after weak study data, but shifts focus to more promising candidates like REC-4881 to regain ground.
USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 7, 2025 /PRNewswire/ -- USA News Group News Commentary - This week in Geneva, the World Health ...
USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 7, 2025 /CNW/ — USA News Group News Commentary – This week in Geneva, the World Health Organization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results